The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884

Clinical characteristics of coronavirus disease 2019 in China

Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246

Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia

Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575

A new coronavirus associated with human respiratory disease in China

Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688

First case of 2019 novel coronavirus in the United States

Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030

Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)

Fiore, A. E., Shay, D. K., Broder, K. R., Iskander, J. K., Uyeki, T. M., Mootrey, G., Bresee, J. S., & Cox, N. S. (2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,006

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020) · Journal of Virology · doi:10.1128/jvi.00127-20 · Cited by 4,341

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

Chan, J. F., Kok, K., Zhu, Z., Chu, H., To, K. K., Yuan, S., & Yuen, K. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,127

Coronavirus envelope protein: current knowledge

Schoeman, D., & Fielding, B. C. (2019) · Virology Journal · doi:10.1186/s12985-019-1182-0 · Cited by 2,149

The spike protein of SARS-CoV — a target for vaccine and therapeutic development

Du, L., He, Y., Zhou, Y., Liu, S., Zheng, B.-J., & Jiang, S. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2090 · Cited by 1,678

COVID-19: A Global Emergency

Wang, L. (2020) · Biomedical Journal of Scientific & Technical Research · doi:10.26717/bjstr.2020.31.005071 · Cited by 2

Analysis of SARS-CoV-2 genomes from across Africa reveals potentially clinically relevant mutationsPreprint

Longjohn, M. N., Egbule, O. S., Danso, S., Akujuru, E. E., Ibubeleye, V. T., Iworah, O. C., Ogharanduku, T., Manu, A. A., & Iweriebor, B. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.08.287201 · Cited by 2

Prefusion conformation of SARS-CoV-2 receptor-binding domain favours interactions with human receptor ACE2Preprint

Kumawat, N., Tučs, A., Bera, S., Chuev, G. N., Fedotova, M. V., Tsuda, K., Kruchinin, S. E., Sljoka, A., & Chakraborty, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.22.441041 · Cited by 2

Vaccines and Treatment Strategies for SARS-COV-2Preprint

Sarkar, A., & Maulik, U. (2020) · doi:10.31219/osf.io/3qzm2 · Cited by 2

Herbal Bioactives for Treating Respiratory Infections

Pardeshi, C. V., Pardeshi, S. R., Naik, J., Shirkhedkar, A. A., & Surana, S. J. (2022) · Wiley eBooks · doi:10.1002/9781119818779.ch5 · Cited by 2

INVESTIGAÇÃO TEÓRICA/PRÁTICA DA EFICÁCIA E DURABILIDADE DOS MATERIAIS TÊXTEIS ANTIVIRAIS NO COMBATE À PANDEMIA DA COVID-19

Vasques, R. S., Leme, N. D. A., Pinheiro, E., Fortunato, F. D. S., & de Brito, M. R. P. (2022) · doi:10.22533/at.ed.64322160210 · Cited by 1

A Borderless Solution Is Needed for A Borderless Complexity, Like COVID-19, the Universal Invader

Mohamed, K., Makuku, R., Rodríguez‐Román, E., Hejleh, A. P. A., Joya, M., Ivanovska, M., Makka, S. A., Islam, M. S., Radwan, N. M., Attig-Bahar, F., et al. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-63761-3_50 · Cited by 1

Human Viruses: Infection, Prevention and Potential Target(s) for Therapy – A Comprehensive Review

Gupta, S., Kumar, P., Das, A. M., Gupta, D., & Das, B. C. (2021) · Springer eBooks · doi:10.1007/978-3-030-71165-8_1 · Cited by 1

COVID-19 Pandemic - Acute Health Challenges for the Human Beings: A Systematic Review

Gupta, D. N., & Gupta, P. S. (2020) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2020.v64i01.007 · Cited by 1

Zagrożenia środowiska i bezpieczeństwo żywności t.1

Nowakowicz-Dębek, B., & Chabuz, W. (2020) · doi:10.24326/mon.2020.8 · Cited by 1

Biological features of SARS-CoV-2 and current approaches to antiviral therapy and vaccination

Lepej, S. Ž., Korać, P., Škorić, D., Batović, M., Gršković, P., Begić, V., Harabajsa, S., Radmanić, L., & Šimičić, P. (2020) · Molecular and experimental biology in medicine · doi:10.33602/mebm.3.2.1

Management of Covid-19 Vaccination for the Elderly

Katuuk, D. A., Lengkong, J. S. J., Rotty, V. N. J., & Tinangon, R. M. (2021) · Budapest International Research and Critics Institute (BIRCI-Journal): Humanities and Social Sciences · doi:10.33258/birci.v4i2.1902 · Cited by 1

NEW MARGINALS, OLD MARGINALS IN THE AGE OF COVID-19 IN INDONESIA

Novenanto, A., Kristama, B. Y., Kurniawaty, Y., Amiruddin, L., Widowati, F., Solekhah, N., Azkia, L., Saputri, E. D., Anam, S. N., Makitan, G., et al. (2021) · Jurnal Masyarakat dan Budaya · doi:10.14203/jmb.v23i1.1161 · Cited by 1

Distinguishing repeated polymerase chain reaction positivity from re‐infections in COVID‐19

Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., ShahmariGolestan, F., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12883 · Cited by 1

Review of Emergence and Zoonotic Implication of Sars-Cov-2 (Covd 19) and its Associated Risk Factors

(2020) · ARC Journal of Animal and Veterinary Sciences · doi:10.20431/2455-2518.0601003 · Cited by 1

Edukasi Taat Protokol Kesehatan 5M, Vaksinasi, serta Menjaga Kebersihan Lingkungan di Jemaat Gereja Protestan Maluku (GPM) Nehemia, Ambon

Arabaling, A. D., Dailangi, C., Matayane, Y., Tipruata, S. E., Latumeten, E., & Nanuru, R. F. (2022) · Panrannuangku Jurnal Pengabdian Masyarakat · doi:10.35877/panrannuangku691 · Cited by 1

Nanoarchitectonics: role of nanomaterials in vaccination strategies for curbing SARs-CoV-2/COVID-19

Zulfiqar, I., Wahab, A., Saeed, M. U., Hussain, N., Sabar, M. F., Bilal, M., & Iqbal, H. M. N. (2022) · Nanofabrication · doi:10.37819/nanofab.007.193 · Cited by 1

Post-Covid-19 irritable bowel syndrome – importance of diet therapy and probiotic therapy

Grońska, D., & Drzewowska, K. (2022) · Medycyna Ogólna i Nauki o Zdrowiu · doi:10.26444/monz/155260 · Cited by 1

Analisis Faktor-Faktor yang Mempengaruhi Kepatuhan Masyarakat dalam Keikutsertaan Vaksinasi Covid-19 di Wilayah Kerja Puskesmas Karang Bahagia

Abdulah, M. B., Sholih, M. G., & Hilmi, I. L. (2022) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v5i2.142 · Cited by 1

A koronavírus válság hatása a kis- és középvállalkozások működésére

Karácsony, P. (2021) · Studia Mundi - Economica · doi:10.18531/studia.mundi.2021.08.04.72-82 · Cited by 1

Effect of vaccine on prognosis and mortality in COVID-19

TEKİN, S., Coşkun, N., Adıyeke, E., Şen, E., Sarı, Ö. T., AYGÜN, M. U., Çetin, A. Ş., Karadağ, F. Y., & Bakan, N. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1176884 · Cited by 1

Evidence of the Existence of a Large Amount of Cationic Antimicrobial Peptides in Propolis, with a Strong Physical/Electrostatic Mechanism of Action (Detergent-like), and their Possible Promising Effects in the Treatment of COVID-19 by means of Propolis Extract InhalationPreprint

Burger, E. A. (2020) · doi:10.22541/au.159231546.68218755 · Cited by 2

Computational design of potential siRNA molecules for silencing of protease (3LC-like proteinase) and RNA-dependent RNA polymerase gene of SARS-CoV-2 by RNAi technologyPreprint

Karim, M. A., Sarker, M. T., Samad, A., Ahammad, F., Karim, M. A., Jaman, J., Karim, Z., Siam, M. K. S., Seraj, Z. I., & Shohan, M. U. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1936787/v1 · Cited by 1

Structural Pathways to Developing Vaccines against Novel Coronavirus (SARS-CoV-2)

Biswas, S. (2020) · Biotechnology Kiosk · doi:10.37756/bk.20.2.3.2

Right to Health under the Pandemic Conditions: Individual-State Cooperation and Interconnectedness

Yukalo, V., & Yukalo, M. (2020) · Postmodern Openings · doi:10.18662/po/11.1sup2/150

A review of COVID-19: Molecular basis, diagnosis, therapeutics and prevention

HUYNH, M. T. N., Nguyen, P., PHAN, H. H. C., Phan, N. T. H., LE, K. H., Truong, N. T. H., Le, K. D., HO, D. V., Nguyen, V. T., Tran, H. L. B., et al. (2020) · Science and Technology Development Journal - Natural Sciences · doi:10.32508/stdjns.v4i3.907

Peer Review #3 of "Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.9572v0.2/reviews/3

Peer Review #3 of "Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9572v0.1/reviews/3

COVID-19: el reto de la prevención y vacunación efectiva

Valdés-Lagunes, D. A., Trimiño-Monroy, C., Lerma-Sánchez, V., & Sánchez-Cárdenas, M. (2020) · Revista Mexicana de Trasplantes · doi:10.35366/94508

Peer Review #1 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9689v0.1/reviews/1

Peer Review #2 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.9689v0.2/reviews/2

Peer Review #2 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9689v0.1/reviews/2

Peer Review #3 of "Genomic diversity and evolution, diagnosis, prevention, and therapeutics of the pandemic COVID-19 disease (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9689v0.1/reviews/3

Repurposing the Natural Compound for Antiviral During an Epidemic -a Case Study on the Drug Repurpose of Natural Compounds to Treat COVID-19Preprint

Wang, Z., Xu, C., Liu, B., & Qiao, N. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12326399.v1

A review of Pharmacological Agents Used to Treat COVID-19 During the Pandemic.

Özatik, F. Y. (2021) · Ahi Evran Medical Journal · doi:10.46332/aemj.805416

SARS-CoV-2 Reinfection within the first 3 months of COVID-19 Recovery in A Referral Hospital, Tehran, IranPreprint

Sadr, S., Bafrani, M. A., Abdollahi, A., SeyedAlinaghi, S., Mohammadnejad, E., Hossienzade, R., Golestan, F. S., Ahmadinejad, Z., Salehi, M., Javaherian, M., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-271345/v1

The Impact of the Coronavirus Crisis on the Operation of Hungarian Small and Medium-sized Enterprises

Karácsony, P., & Vasa, L. (2020) · Polgári szemle · doi:10.24307/psz.2021.0127

Policy Options of the Bengkalis Regional Government in Handling the National Disaster Covid-19 and Its Impact on Community Economic Growth

Asra, Y., & Pratama, A. I. (2021) · Advances in Social Science, Education and Humanities Research/Advances in social science, education and humanities research · doi:10.2991/assehr.k.210424.050

Investigating the Inhibition Effect of Portulaca oleracea against SARS-CoV-2 through Molecular Docking Simulation

El-hoshoudy, A. N., Zaki, E. G., & Elsaeed, S. M. (2021) · Austin Journal of Analytical and Pharmaceutical Chemistry · doi:10.26420/austinjanalpharmchem.2021.1132

In Silico Study of SARS-CoV-2 Vaccine Candidate: Spike Glycoprotein

Ansori, A. N. M. (2021) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v15i2.14732

PENGADAAN TEMPAT CUCI TANGAN SEDERHANA SEBAGAI LANGKAH PENCEGAHAN PENYEBARAN COVID19

Indiworo, H. E., Sumastuti, E., & Ratih Hesty Utami, P. (2021) · Indonesian Journal Of Community Service

A DYNAMIC MODEL FOR COVID-19 THERAPY WITH DEFECTIVE INTERFERING PARTICLES AND ARTIFICIAL ANTIBODIES

Zhao, Y., & Xing, Y. (2021) · Journal of Applied Analysis & Computation · doi:10.11948/20210102

Strategies and Challenges in the Development of Coronavirus Disease-2019 Vaccine

Gupta, P. (2021) · Epidemiology - Open Journal · doi:10.17140/epoj-6-122

Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"

(2021) · PeerJ · doi:10.7287/peerj.12548v0.1/reviews/1

Peer Review #3 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"

(2021) · PeerJ · doi:10.7287/peerj.12548v0.1/reviews/3

Pemberian Vaksinasi Covid-19 Kepada Masyarakat Sebagai Wujud Pemenuhan Hak Asasi Manusia Di Bidang KesehatanPreprint

Hidayanti, A. N. (2021) · doi:10.31219/osf.io/9aenw

Peer Review #1 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.2)"

(2021) · PeerJ · doi:10.7287/peerj.12548v0.2/reviews/1

Peer Review #2 of "EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes (v0.1)"

(2021) · PeerJ · doi:10.7287/peerj.12548v0.1/reviews/2

Full Issue PDF

(2020) · JACC Basic to Translational Science · doi:10.1016/s2452-302x(20)30205-9

OS DESAFIOS DE UMA EMPRESA DE TRANSPORTE DE PETRÓLEO NO PERIODO DA PANDEMIA DE COVID-19

Sousa, I. C., Lima, K. R. A. D. A., de Matos, T. N. F., & Catrib, A. M. F. (2022) · doi:10.22533/at.ed.64322160212

COMPLIANCE COMO FERRAMENTA PARA ENFRENTAMENTO DA PANDEMIA (COVID-19)

de Sousa, T. S., & Bertão, S. M. (2022) · doi:10.22533/at.ed.64322160211

CONTRIBUTO DO ENFERMEIRO ESPECIALISTA NO ÂMBITO DO DESENVOLVIMENTO INFANTIL NO IMPACTO DA COVID-19 NA INFÂNCIA

Rocha, J. S. B., Chora, M. A. F. C., & Antunes, A. S. A. (2022) · doi:10.22533/at.ed.6432216025

ARTRITE REUMATOIDE E COVID-19: UM RELATO DE CASO

Tuni, D. C., Daga, F. A., & Filho, J. C. M. (2022) · doi:10.22533/at.ed.6432216027

A Study on Post Vaccination Symptoms after First and Second Dose of vaccine in Western UP and Delhi NCR.

Sharma, N., & Singhal, S. (2022) · YMER Digital · doi:10.37896/ymer21.03/03

IDENTIFY THE CURRENT TRENDS RELATED TO THE TREATMENT AND PREVENTION OF COVID- 19

Bansal, S. (2022) · Sachetas · doi:10.55955/110004

Peer Review #2 of "Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9572v0.1/reviews/2

Pemberian Vaksinasi Covid-19 Kepada Masyarakat Sebagai Wujud Pemenuhan Hak Asasi Manusia Di Bidang KesehatanPreprint

Hidayanti, A. N. (2021) · doi:10.31219/osf.io/4p6uk

Peer Review #1 of "Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9572v0.1/reviews/1

Repurposing the Natural Compound for Antiviral During an Epidemic -a Case Study on the Drug Repurpose of Natural Compounds to Treat COVID-19Preprint

Wang, Z., Xu, C., Liu, B., & Qiao, N. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12326399

Review Of Covid-19 Vaccines

Musafer, H. K., Abdulrazaq, R. A., Ali, B. M., & Kaabi, S. A. G. (2021) · Journal of university of Anbar for pure science · doi:10.37652/juaps.2022.172451

Repurposing BCG and MMR Vaccines for Combating COVID-19: A Review and Opinion Based on Clinical Evidence

Tawde, K. M., Iyer, A. M., & Pawar, H. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.106788

Development of a gas chromatography-mass spectrometry method for determination of β-propiolactone (BPL) residues in inactivated covid-19 vaccinesPreprint

Mirjalili, S. Z., Tamiji, Z., Shirangi, M., & Amini, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2484556/v1

Therapeutic Potential of Nitric Oxide in the Management of COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS)

Joshi, J. C., & Joshi, B. (2023) · Advances in biochemistry in health and disease · doi:10.1007/978-3-031-24778-1_12

Pengaruh Dukungan Kesehatan Jiwa dan Psikososial terhadap Tingkat Kecemasan Orang Dengan Komorbid (ODK) Sebelum dan Sesudah Menerima Vaksin Covid-19

Permatasari, D. P., Windarwati, H. D., & Azizah, N. (2023) · Jurnal Keperawatan · doi:10.32583/keperawatan.v15i2.1048

Vaccination Problem: Matching Theory Approach in Vaccination Against CoronavirusPreprint

Harooni, H. A., & Gordji, M. ‎. (2023) · Preprints.org · doi:10.20944/preprints202307.1308.v1

Penerapan Akupresur sebagai bagian Adaptasi Kebiasaan Baru untuk Meningkatkan Imunitas

Siyamti, D., Sari, K., & Adimayanti, E. (2023) · Jurnal Pengabdian Perawat · doi:10.32584/jpp.v2i1.2072

GAMBARAN TINGKAT PENGETAHUAN DAN SIKAP MASYARAKAT TERHADAP VAKSINASI COVID-19: SEBUAH TINJAUAN PUSTAKA

Suparto, Jumriana, & Perangin-angin, C. R. (2023) · Journal of Scientech Research and Development · doi:10.56670/jsrd.v5i1.91

IMPLEMENTATION OF THE HEALTH BELIEF MODEL (HBM) CONCEPT ON THE USE OF THE COVID_19 VACCINE. POPULATION CROSS SECTIONAL STUDY IN WEST JAVA PROVINCE

Salman, S., Setiawan, M. A., Nurdiana, A., & Nilasari, N. (2023) · Proceedings of the 2nd International Conference on Social Science (ICSS) · doi:10.59188/icss.v2i2.138

A Systematic Review - Adverse Effect of Covid-19 Vaccine

Kumar, A., Singh, A., & Gupta, B. K. (2025) · Asian Journal of Research in Chemistry · doi:10.52711/0974-4150.2025.00031

Comprehensive and translational pathobiology of COVID-19 based on cellular and molecular techniques

Samadani, A. A., Vahidi, S., Babaei, K., Norollahi, S. E., Delpasand, K., & Gharakhyli, E. A. (2025) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2025.e00497

Associations of COVID-19 Vaccination and Symptom Severity with SARS-CoV-2 Infection in the Framingham Heart Study

Prescott, B. R., Vasan, R. S., Murabito, J. M., & Xanthakis, V. (2026) · COVID · doi:10.3390/covid6100184

BindingDB Entry 50018744: Fight against novel coronavirus: A perspective of medicinal chemists.

BindingDB (2024) · UC San Diego · doi:10.7270/q2br8xdw

Vaccines and Treatment Strategies for SARS-COV-2Preprint

Sarkar, A., & Maulik, U. (2020) · doi:10.31219/osf.io/3qzm2 · Cited by 2

Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Anand, U., Jakhmola, S., Indari, O., Jha, H. C., Chen, Z., Tripathi, V. S., & de la Lastra, J. M. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658519 · Cited by 84

SARS-CoV-2 Leading Vaccine Candidates: Progress and Development

Amraiz, D., Fatima, M. T., & Navid, M. T. (2020) · Life and Science · doi:10.37185/lns.1.1.153 · Cited by 2

Targets and strategies for vaccine development against SARS-CoV-2

Malik, J. A., Mulla, A. H., Farooqi, T., Pottoo, F. H., Anwar, S., & Rengasamy, K. R. R. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111254 · Cited by 81

Vaccination strategies to combat novel corona virus SARS-CoV-2

Pandey, S. C., Pande, V., Sati, D., Upreti, S., & Samant, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117956 · Cited by 125